News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    

Biotech/Pharma - Mergers and Acquisitions
Baxalta (BXLT) Shareholders Vote To Approve Combination 5/27/2016
Medivation (MDVN) Files Preliminary Consent Revocation Statement 5/27/2016
Advanced Accelerator Applications Expands Its Presence In Germany With Strategic Acquisition Of Two Production Sites 5/27/2016
Embattled Valeant (VRX) Reportedly Spurned a Takeover Offer from Takeda (TKPYY)-TPG 5/27/2016
Thermo Fisher Scientific (TMO) Expands into Pharma Market, Antes Up $4.2 Billion for FEI Company 5/27/2016
BioStem Technologies Acquires TEN Health Behavior Change Platform 5/27/2016
Count Celgene (CELG) and Gilead (GILD) as New Suitors to Acquire the Popular Medivation (MDVN) 5/26/2016
Armetheon Completes Acquisition Of Budiodarone And Plans Development For The Treatment Of Ventricular Tachycardia In Patients With Implantable Cardioverter Defibrillators 5/26/2016
Amulet Capital Partners, LP Announces Acquisition Of SynteractHCR 5/26/2016
Israeli Startup HIL Applied Medical Acquires US-Based Nanolabz Inc. - En Route To Developing Advanced Cancer Radiotherapy Systems 5/26/2016
Making Sense of Alnylam (ALNY)’s Recent Stock Surge 5/26/2016
Ensemble Therapeutics Corporation Announces Global Pharma Partner Expands Access To IL-17 Assets 5/25/2016
Dr. Reddy's Laboratories Ltd. (RDY)’s Enters The Branded Consumer Health Arena Through The Acquisition Of Six OTC Brands 5/25/2016
Thunderbolt Pharma, Inc., A Vitesse Biologics Company, Acquires Rights To BAFF/APRIL Dual Antagonist Program From Astellas Pharma Inc. 5/25/2016
Amid Restructuring and Lawsuits, Novartis AG (NVS) Indicates It Might Sell $14 Billion Roche (RHHBY) Stock Without a Premium 5/25/2016
Sanofi (SNY) Formally Files Papers to Oust the Medivation (MDVN) Board that Rejected Its $9.3 Billion Bid 5/25/2016
Spero Acquires Novel Gyrase Inhibitors From Vertex (VRTX) 5/25/2016
PDL BioPharma (PDLI) Bags Novartis AG (NVS)'s Hypertension Drugs Via $107 Million Investment in Noden Pharma 5/25/2016
Medivation (MDVN) Urges Stockholders To Reject Sanofi (SNY)’s Attempt To Replace Medivation Board Of Directors 5/25/2016
Allergan (AGN) Eyes Smaller M&A Deals After $40.5 Billion Sale of Its Generics Unit to Teva (TEVA) is Completed 5/24/2016
M&A Targets Pfizer (PFE) and Others Could be Eyeballing 5/24/2016
Exiqon A/S Has a Backup Plan if Takeover Offer by QIAGEN N.V. (QGEN) Fails 5/24/2016
W. R. Grace & Company Focuses Its Pharma, Nutraceutical Business; Sells Chromatography Instruments, Columns, And Related Laboratory Product Lines 5/24/2016
Eurofins BioDiagnostics Merges With Eurofins STA To Strengthen Position In The Seed, Plant, And AgBio Diagnostics Markets 5/24/2016
Innovus Pharma Joins AbbVie (ABBV) And Eli Lilly (LLY) In The Race For The $3 Billion Testosterone Replacement Market 5/24/2016
Arbor Pharma Shells Out $467 Million for Bay Area’s Restless Leg Drug Company XenoPort (XNPT) 5/24/2016
Amid Shareholder Pressure, Bayer (BAY) Makes Formal $62 Billion Bid for Monsanto  (MON) 5/24/2016
MD Anderson Cancer Center And Varian Medical Systems (VAR) Expand Relationship With Acquisition Of TrueBeam Systems 5/23/2016
Luminex (LMNX) Sweetens Nanosphere Bid to $102 Million 5/23/2016
Week In Review: Big Deals Headline This Week's Life Science News 5/23/2016
Recipharm AB Completes Acquisition Of Kemwell Pharma And Cirrus Pharmaceuticals, Inc. And Resolve On Share Issues 5/23/2016
Baxalta (BXLT) Announces Preliminary Merger Consideration Election Results 5/23/2016
About 500 Kendall Square Baxalta (BXLT) Staffers in Limbo as Shire (SHPG) Merger Talks Drag On 5/20/2016
Allenex AB: CareDx (CDNA) Initiates Compulsory Acquisition Proceedings And Allenex Files For De-Listing 5/20/2016
Horizon Pharma (HZNP) To Acquire Worldwide Rights To Interferon Gamma-1b From Boehringer Ingelheim International GmbH 5/20/2016
Novanta (GSIG) To Acquire Reach Technology, Inc. 5/19/2016
Mylan (MYL) Updates Timetable For Commencement Of Acceptance Period For Offer For MEDA 5/19/2016
Siemens (SI) Bags Cancer Diagnostic Firm Neo New Oncology for Undisclosed Sum 5/19/2016
QIAGEN N.V. (QGEN) Extends Tender Offer Period For Acquisition Of Exiqon A/S 5/19/2016
Alvotech Announces Acquisition Of Baliopharm 5/19/2016
Why Investors Should be Insulted Over Bayer AG (BAYZF)'s $40 Billion Offer for Monsanto  (MON) 5/19/2016
Embattled Valeant (VRX) Mulls Over Selling Skin, Cancer Drugs to Cut Debt 5/18/2016
Smith & Nephew plc (SNN) Sells Truclear Gynecology Biz to Medtronic (MDT) for $350 Million 5/18/2016
PENTAX Medical Company Acquires Controlling Stake in SIMMEDICA 5/18/2016
Quest Diagnostics (DGX) Completes Effort To Refocus On Diagnostic Information Services; Updates 2016 Revenue Outlook 5/18/2016
Fosun Pharma In $1-$1.5 Billion Bidding War For India's Gland Pharma 5/18/2016
Delving Into Pfizer (PFE)’s Anacor (ANAC) Acquisition Strategy and Its Impact on Regeneron (REGN) 5/17/2016
Metabolix Evaluating Strategic Alternatives for its Biopolymers and Yield10 Businesses 5/17/2016
PBM Capital Acquires Phase III Platelet Drug For Chronic Liver Disease Patients 5/17/2016
Nimbus Therapeutics Announces Closing Of Gilead (GILD)’ Acquisition Of Nimbus Apollo, Inc., And Its Acetyl-CoA Carboxylase (ACC) Inhibitor Program 5/17/2016
In Another Small Deal, Pfizer (PFE) Slams Down $5.2 Billion for Bay Area Drugmaker Anacor (ANAC) 5/17/2016
Shire (SHPG) Could be Eyeing Biogen (BIIB)'s Hemophilia Biz 5/16/2016
Teva (TEVA)'s European Portfolio Attracts Interest from Mylan (MYL) and Novartis AG (NVS), Sale Could Bring in $1.5 to $2 Billion 5/16/2016
Zimmer Biomet Completes Acquisition Of Cayenne Medical 5/16/2016
DiaSorin S.p.A. Completes Acquisition Of The Focus Diagnostics' Molecular And Immunoassay Product Business From Quest Diagnostics (DGX) 5/16/2016
GE Healthcare's Dealmaking CEO Looks Isn't Interesting in M&A, Seeks Growth from Within Instead 5/16/2016
Only Days After a Follow-On Offering, San Diego's Sophiris Bio (SPHS) Hires Oppenheimer to Explore Strategic Options 5/13/2016
Gutsy Sanofi (SNY) to Nominate 8 Directors for Medivation (MDVN) Board, Files Pre-Merger Papers 5/13/2016
Evaluating Amgen (AMGN) and Sanofi (SNY)'s Individual Needs for Medivation (MDVN) 5/13/2016
Baxter International (BAX) Emerges as Frontrunner in $1.2 Billion Bid for Gland Pharma 5/13/2016
Takara Bio Gobbles Up WaferGen Biosystems in $50 Million All-Cash Deal 5/13/2016
Mylan (MYL) Pays $950 Million Cash for Renaissance's Specialty And Generics Business 5/13/2016
WaferGen Biosystems And Takara Bio Announce Merger Agreement 5/13/2016
Bayer (BAY) Rumored to be Exploring Bid for $40 Billion Seed Company Monsanto  (MON) 5/12/2016
Galileo Life Sciences, Inc. Merges With Novo Healthnet Ltd. 5/12/2016
Amcor Rigid Plastics Continues Growth Strategy With Acquisition Of Plastic Moulders Limited 5/12/2016
Bay Area's Alexza Pharma (ALXA) Sold in $35 Million Deal 5/11/2016
LABWORKS LIMS Acquired From PerkinElmer (PKI) By Labworks LLC – Future Never Looked Brighter 5/11/2016
Jazz Pharma (JAZZ) Snaps Up Alizé Pharma II For 18 Million Euros 5/11/2016
Roche (RHHBY) Has No Plans to Unload Diabetes Testing Business Despite Three Year Low from U.S. Price Cuts 5/11/2016
Medivation (MDVN) Takeover Saga Takes Another Turn, Rumored to Open Books to Amgen (AMGN) and Pfizer (PFE) 5/11/2016
San Diego's Sorrento (SRNE) Hires Advisors to Mull Over Strategic Options 5/10/2016
Gilead (GILD) CEO Targets Cancer Acquisitions with $21 Billion Cash Pile 5/10/2016
RXi Pharma (RXII) to Explore Strategic Options, Including Possible M&A 5/10/2016
Johnson & Johnson (JNJ)'s DePuy Synthes Snaps Up BioMedical Enterprises for Undisclosed Amount 5/10/2016
Aptuit LLC Announces Acquisition Of Kuecept Ltd 5/10/2016
Incyte (INCY) Buys Ariad (ARIA)'s EU Operations and Iclusig Rights for $140 Million Upfront 5/9/2016
Acadia (ACAD) Drug Approval May Make It an Attractive Target for Biogen (BIIB), Teva (TEVA) 5/9/2016
The Medicines Company (MDCO) Agrees To Divest Non-Core Cardiovascular Assets To Chiesi Farmaceutici SpA 5/9/2016
The Medicines Company (MDCO) Divests Cardiovascular Assets to Chiesi Farmaceutici SpA for Up to $792 Million 5/9/2016
Woodbridge International Closes ImmunosticsBoditech Med Deal 5/9/2016
Week In Review: Sinocare Acquires Second US Diagnostics Maker; Pays $200 Million 5/9/2016
SYGNIS To Acquire Expedeon Holdings 5/9/2016
Amgen (AMGN) Rumored to be Another Medivation (MDVN) Suitor 5/6/2016
Sanofi (SNY) Heats Up Medivation (MDVN) Bid With Letter Threatening a Hostile Takoever 5/6/2016
BTG plc (BTG.L) Snaps Up Tumor Freezing Firm Galil Medical in $110 Million Deal 5/6/2016
AMRI (AMRI) Bags Euticals in $358 Million Cash-Stock Deal 5/5/2016
Biogen (BIIB)'s Hemophilia Spinoff Suggests M&A Activity Could Be On the Horizon 5/5/2016
Sanofi (SNY) CEO Sees a Strong Strategic Fit with Medivation (MDVN) 5/5/2016
ReWalk (RWLK) Release: Department Of Veterans Affairs Purchases 20 Rewalk Systems To Support National Multi-Center Trial Assessing Personal Exoskeleton System Use 5/5/2016
Medivation (MDVN) Reiterates Rejection of Sanofi (SNY)'s $9.3 Billion Bid 5/5/2016
Luye Medical Welcomes Australia's Healthe Care To Its Group, Leading The Way For Group Expansion In Asia 5/5/2016
IMS Health, Quintiles (Q) to Merge to Form $23 Billion Power House 5/4/2016
Bay Area’s Medivation (MDVN) Shores Up Defenses as Pfizer (PFE) Rumored to Join Sanofi (SNY) in Acquisition Bid 5/4/2016
Bio-Techne (TECH) Acquires Access To B-MoGen Biotechnologies' Gene Editing Technology 5/4/2016
Halyard Health Announces First Quarter 2016 Results Completes Acquisition Of CORPAK MedSystems 5/4/2016
Ligand (LGND) Acquires Portfolio Of Synthetic Royalty And Milestone Rights From Cormatrix Cardiovascular For $17.5 Million 5/4/2016
Miroculus Acquires Kapplex To Advance Diagnostics For Complex Diseases 5/4/2016
Why a Medivation (MDVN) Takeover Just Got a Little Tougher for Potential Suitors Like AstraZeneca PLC (AZN), Pfizer (PFE) and Sanofi (SNY) 5/3/2016
Pfizer (PFE) Rumored to be Selling Its Hospira Pumps Division, With Smiths Group, Fresenius SE and Pamplona Capital Bidding 5/3/2016
PE Firm Snaps Up Symmetry Surgical in $140.3 Million Deal 5/3/2016
Marina Biotech (MRNA) Calls Off Sale of Its Nucleic Acid Therapeutic Assets to Microlin Bio 5/3/2016
As Sarepta (SRPT) And Valeant (VRX) Exit Hearings, Biotech Steps Into M&A 5/3/2016
Precision For Medicine Acquires Applied Immunology 5/3/2016
Axiogenesis Secures Major Funding For Its Expansion Course 5/3/2016
Marina Biotech (MRNA) Acquires Late-Stage Program from Turing in $95 Million Deal 5/3/2016
Neogen Corporation (NEOG) Acquires Preserve International And Tetradyne 5/2/2016
Letter Of Intent To Acquire NovaRx Corporation Expires; Viropro Inc. (VPRO) Appoints New Slate Of Officers 5/2/2016
Cipher Pharma (DND.TO) Acquires Worldwide Rights To Dalhousie University's Investigational Tattoo Removal Cream 5/2/2016
Veristat, Inc. Expands Its Clinical Operations Into Europe 5/2/2016
Sinocare Coughs Up $200 Million Cash for PTS Diagnostics 5/2/2016
Abbott (ABT) Tries to Back Out of $5.8B Alere (ALR) Deal, But Alere Says It’s Still On 5/2/2016
4SC AG (VSC.F) Sells Operations Of Its Discovery Division 4/29/2016
Medivation (MDVN) Says No! to Sanofi (SNY)'s $9.3 Billion Hostile Bid 4/29/2016
AbbVie (ABBV) Pays $5.8 Billion+ for Bay Area's Stemcentrx, Which Has Ties to Paypal and SpaceX Investors 4/29/2016
Medivation (MDVN)'s Road from Penny Stock to $9.3 Billion M&A Target 4/29/2016
AstraZeneca PLC (AZN) Stays Mum on M&A, Says “No Comment” to Medivation (MDVN) Bid 4/29/2016
Sanofi (SNY) Makes Hostile $9.3 Billion Bid for Bay Area’s Medivation (MDVN) 4/29/2016
Stryker (SYK) Coughs Up $52 Million for Stanmore Implants 4/29/2016
Alere (ALR) Obtains Requisite Lender Approval For Extension To File Form 10-K; Announces Certain Developments Relating To The Pending Merger Transaction With Abbott (ABT) 4/29/2016
Abbott (ABT)'s $25 Billion Bid for St. Jude Medical (STJ) Raises Questions About Pending Alere (ALR) Deal 4/28/2016
The M&A Rumor Mill Points to Gilead (GILD) Acquiring Intercept Pharma (ICPT) 4/28/2016
Rumors Surface Again About AstraZeneca PLC (AZN), Sanofi (SNY) or AbbVie (ABBV) Acquiring Medivation (MDVN) 4/27/2016
Johnson & Johnson Consumer Snaps Up New Jersey's NeoStrata's for Undisclosed Sum 4/27/2016
Neogen Corporation (NEOG) Acquires Brazilian Animal Genomics Company 4/27/2016
Toshiba Got the Cash for Its Medical Biz Before the Deal Closed 4/27/2016
Nokia Bets on Digital Health with $190 Million Buy 4/27/2016
Ironwood (IRWD) to Fork Over Up to $256 Million Plus Royalties to AstraZeneca PLC (AZN) for U.S. Rights to Gout Drug 4/26/2016
Novartis AG (NVS) Mulls Over Selling $14 Billion Roche (RHHBY) Stake to Potentially Free Up Cash for New Deals 4/26/2016
MD Anderson Cancer Center To Acquire Elekta Linear Accelerators And Other Radiotherapy Solutions 4/26/2016
DNA 2.0, Inc. Acquires MIGS To Add Antibody Production Capabilities 4/26/2016
Alere (ALR) Received Notice of Default from Group of Bondholders 4/26/2016
Bay Area’s Relypsa (RLYP) Stock Pops (Again) on More Buyout Rumors 4/25/2016
Allergan (AGN) Makes Another Deal, Bags Boston's Topokine for $85 Million+ 4/25/2016
Aytu BioScience Enters $2 Billion Testosterone Replacement Market With Acquisition Of U.S. Commercial Rights To Natesto 4/25/2016
Zimmer Biomet Enters Into Definitive Agreement To Acquire Cayenne Medical 4/25/2016
Singapore-Based Luye Medical Group Completes Acquisition Of Healthe Care, Australia's Third Largest Private Healthcare Group 4/25/2016
NOVACYT Raises €7.75 Million To Complete The Acquisition Of Primerdesign Ltd 4/25/2016
Immune Therapeutics Signs Binding Letter Of Intent To Acquire Chinese CAR-T Technology And Clinical Data 4/25/2016
Biogen (BIIB), Regeneron (REGN) and Valeant (VRX) Rank High as Potential Takeover Targets for Allergan (AGN) 4/22/2016
Concordia (CXR.TO) Stock Rockets on Rumors of a Blackstone Buyout 4/22/2016
Alere (ALR) Stock Falls as Abbott (ABT) CEO Declines to Comment and Confirm $6 Billion Deal 4/22/2016
Nexeon MedSystems, Inc. Announces Acquisition Of Neuromodulation IP From Health Wildcatters Graduate Neurotek Medical 4/22/2016
Aptuit LLC Announces Acquisition Of Exquiron 4/21/2016
Bionik Laboratories Announces Closing Of Acquisition Of Interactive Motion Technologies Inc. 4/21/2016
Becton, Dickinson and Company (BDX) Divests Vertebral Augmentation Solutions Business To Stryker (SYK) 4/21/2016
Becton, Dickinson and Company (BDX) Divests Vertebral Augmentation Solutions Business to Stryker (SYK) for Undisclosed Amount 4/21/2016
Nanoantibiotics Acquires Company Developing Novel Therapies For Liver Disease 4/20/2016
Auris Surgical Robotics Snaps Up Bay Area's Hansen Medical (HNSN) in $80 Million Deal 4/20/2016
Allergan (AGN)'s Potential Shopping List Expands 4/19/2016
Covered in $30 Billion Debt, Embattled Valeant (VRX) Mulls Over Which Assets to Sell 4/19/2016
A Week After Medivation (MDVN) Rumored to Snub Sanofi (SNY) Bid, AstraZeneca PLC (AZN) in Talks to Make Its Own $10 Billion Offer 4/19/2016
Avioq Announces the Completion Of Its Acquisition By Oriental Ocean Sci-tech Co., Ltd. 4/19/2016
Recipharm AB Creates A Global CDMO Leader Through SEK 1.7 Billion Strategic Acquisitions In The US, Sweden And India 4/18/2016
InfuSystem, Inc. (IFLO) Agrees To Acquire Infusion Pump Assets From InfusAID, LLC 4/18/2016
Tricol International Group Limited Completes Asset Acquisition Of HemCon Medical 4/18/2016
China’s Venus Medtech Snaps Up Transcatheter Technologies 4/18/2016
PROMETHERA Biosciences S.A./N.V. Acquires Key Assets Of Cytonet LLC To Create The Global Leader In Regenerative Medicine And Cell Therapy For Liver Diseases 4/18/2016
Bay Area's Carbylan to Suspend Clinical Development of Hydros-TA and Slash Jobs to Conserve Cash 4/15/2016
Promising Hep B Drug Makes SoCal's Arrowhead Pharma (ARWR) a Pretty Target for Gilead (GILD) and Other Big Companies 4/15/2016
3 Biotechs Might Have M&A Targets On Their Backs 4/15/2016
If Pfizer (PFE) Wants to Buy, Here’s a Shopping List 4/15/2016
Embattled Valeant (VRX) Working with Banks to Review Options Amid Interest from Buyout Firms 4/15/2016
OSE Pharma And Effimune Announce The Signing Of The Merger Treaty To Create OSE Immunotherapeutics 4/15/2016
Elorac, Inc. Acquires Gideon Pharma 4/15/2016
WuXi AppTec Acquires CRELUX GmbH 4/15/2016
Advent, Baxter International (BAX) Preparing Bids for Private Indian Drugmaker Gland Pharma 4/15/2016
New Jersey's Catalent (CTLT) Jumps on Rumors of Lonza Group (LZAGY.PK)'s Takeover Bid 4/14/2016
After Exploring Strategic Alternatives, Synta (SNTA) Agrees to Merge with Madrigal to Create Leading Cardio-Metabolic Diseases and NASH Company 4/14/2016
Bay Area’s Medivation (MDVN) Stock Pops 11% After Rumors It Rejected A Sanofi (SNY) Acquisition Bid 4/14/2016
Ethicon (JNJ) Announces Completion Of Acquisition Of NeuWave Medical 4/14/2016
Novogene Establishes First U.S. Genomic Sequencing Center Located At UC Davis; Acquires Second Illumina (ILMN) Hi-Seq X Ten System 4/14/2016
CryoLife (CRY) Exercises Right to Acquire PhotoFix Bovine Pericardium Patch From Genesee BioMedical 4/14/2016
While Exploring Sale of Its Hemophilia Unit, Some Speculate Biogen (BIIB) Might be Prepping to Buy or be Acquired 4/13/2016
Fresh Off Its $1.2 Billion Deal, Gilead (GILD) Has Cash to Go Shopping Again 4/13/2016
The Female Health Company And Aspen Park Pharmaceuticals To Discuss The Proposed Merger 4/13/2016
BUCHI Labortechnik AG Acquires Flash Chromatography And ELSD Product Lines From Grace 4/12/2016
Sources Reveal Biogen (BIIB) is Exploring Sale of Hemophilia Assets 4/12/2016
Incoming Bayer (BAY) CEO Has Big Plans to Beef Up Animal Health Unit with Deals and Acquisitions 4/12/2016
EUSA Pharma Announces Acquisition Of Global Rights To Next Generation Oncology Supportive Care Product Arcoral Tab From Arcoral Pharma 4/12/2016
Halyard Health Shells Out $174 Million for CORPAK MedSystems 4/12/2016
The Valence Group Advises Eurazeo On Its Acquisition Of Novacap From Ardian 4/12/2016
Bay Area’s Relypsa (RLYP) Stock Pops At Sale Rumors While Waiting For Potential AstraZeneca PLC (AZN) Competition 4/11/2016
Ossur (OSSR) Coughs Up $39 Million for Touch Bionics 4/11/2016
Stryker (SYK) Acquires Safewire Product Portfolio For Use In Minimally-Invasive (MIS) Spine Procedures 4/11/2016
Recipharm AB Completes Acquisition Of A Majority Stake In Indian CMO Nitin Lifesciences 4/11/2016
Valeant (VRX)’s Ackman Says Company Will Not Sell Bausch & Lomb 4/8/2016
Mach 7 Technologies And 3D Medical Complete Merger 4/8/2016
Diversis Capital Acquires Caligor Rx, A Leader In Clinical Trial Supply And Logistics Services 4/8/2016
Allergan (AGN) Chief Brent Saunders On Failed Pfizer (PFE) Deal And Why He's Not Like Valeant (VRX) 4/8/2016
Nixed Pfallergan Deal Has Investors Wondering if Allergan (AGN) Might Target Biogen (BIIB) 4/7/2016
Pfizer (PFE) Formally Calls Off $160 Billion Allergan (AGN) Deal 4/7/2016
Why Biogen (BIIB) May Not be Allergan (AGN)'s Cup of Tea 4/7/2016
Shire (SHPG) Not Spooked by Pfallergan Breakup, Remains Committed to Baxalta (BXLT) 4/7/2016
Two Buys Make Adavium the Largest Brazilian Medical Equipment and Diagnostics Company, Nabs $21 Million 4/7/2016
Pfizer (PFE) Inside Source Says Company Considering Abandoning Allergan (AGN) Deal 4/6/2016
Twist Bioscience Acquires Genome Compiler To Add Gene Design Capabilities 4/6/2016
Ampronix Assumes Specific Perkins Healthcare Technologies Assets 4/6/2016
BioChain Acquires China Rights To Epigenomics AG' Lung Cancer IVD 4/6/2016
Pragma Pharmaceuticals, LLC Announces Acquisition Of Keflex 4/6/2016



//-->